Strata Critical Medical lifts 2026 revenue outlook to $285-$295 million

Reuters2026/08/04 11:20

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Strata Critical Medical raised 2026 revenue guidance to $285-295 million from $260-275 million; lifted 2026 Adjusted EBITDA outlook to $33-35 million from $29-33 million.
On a pro forma basis assuming recent Clinical acquisitions closed Jan. 1, 2026, guidance implies revenue of $295-305 million; Adjusted EBITDA of $36-38 million.
Free Cash Flow outlook, before aircraft acquisitions, reaffirmed at $15-22 million for 2026; higher M&A cash costs, working-capital build expected to offset EBITDA gains.
Logistics revenue expected to fall high-single-digits sequentially in Q3 on seasonality, a roughly 3% revenue headwind; recover to near Q2 levels in Q4.
Clinical revenue forecast to rise about 20% sequentially in Q3; mid-single-digit sequential growth expected in Q4; Clinical gross margin seen at 27-28% in H2.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Strata Critical Medical Inc. published the original content used to generate this news brief on August 04, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Strata Critical Medical lifts 2026 revenue outlook to $285-$295 million

You may also like

Crypto prices